In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Hylate Drug Master File in Korea (Hylate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Hylate. The MFDS reviews the Hylate KDMF as part of the drug registration process and uses the information provided in the Hylate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Hylate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Hylate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Hylate suppliers with KDMF on PharmaCompass.